[Papilla and pancreas cancer. An epidemiologic-clinical case control study of 298 patients].
The study is based on the case records of 816 in-patients (256 adenocarcinoma of the pancreas, 42 carcinoma of Vater's papilla and 518 controls) admitted to the Surgical Clinic of Münster University between 1974 and 1982. With respect to preliminary diseases only pancreatitis and cholecystectomy showed a significant difference between cancer group and control group. 36% of the patients with ampullary and 6.7% with pancreas cancer survived the five-year limit. Prognosis was best among patients over 60.
D000230:Adenocarcinoma / Q000209:etiology / Q000601:surgery*; D000328:Adult; D000368:Aged; D014670:Ampulla of Vater / Q000601:surgery*; D002763:Cholecystectomy; D003138:Common Bile Duct Neoplasms / Q000209:etiology / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000209:etiology / Q000601:surgery*; D010195:Pancreatitis / Q000150:complications; D011183:Postoperative Complications / Q000401:mortality / Q000601:surgery; D011379:Prognosis; D012306:Risk
Das Papillen- und Pankreaskarzinom. Eine epidemiologisch-klinische Fall-Kontrollstudie von 298 Patienten.